Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-16 Purchase | 2022-12-19 07:09 am | NRX Pharmaceuticals Inc. | NRXP | VAN VOORHEES SETH CHIEF FINANCIAL OFFICER | 30,000 | $1.1 | $33,000 | 46,337 (Direct) | View |
| 2022-11-25 Purchase(A) | 2022-12-19 07:08 am | NRX Pharmaceuticals Inc. | NRXP | VAN VOORHEES SETH CHIEF FINANCIAL OFFICER | 16,337 | $1.115 | $18,215 | 16,337 (Direct) | View |
| 2022-11-25 Purchase | 2022-11-28 07:42 am | NRX Pharmaceuticals Inc. | NRXP | VAN VOORHEES SETH CHIEF FINANCIAL OFFICER | 16,337 | $1.115 | $18,215 | 16,377 (Indirect) | View |
| 2021-06-15 Purchase | 2021-06-17 6:52 pm | PDS Biotechnology Corp | PDSB | VAN VOORHEES SETH Chief Financial Officer | 17,647 | $8.5 | $150,000 | 17,647 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2022-06-29 6:14 pm | 2023-06-13 2032-06-12 | NRX Pharmaceuticals Inc. | NRXP | VAN VOORHEES SETH Chief Financial Officer | 0 | $0 | 325,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:06 pm | N/A 2031-01-04 | PDS Biotechnology Corp | PDSB | VAN VOORHEES SETH Chief Financial Officer | 202,800 | $0 | 202,800 (Direct) | View |
| 2020-02-21 Tax Withholding | 2020-02-24 4:30 pm | N/A N/A | RESEARCH FRONTIERS INC | REFR | VAN VOORHEES SETH CFO & VP-Business Development | 4,661 | $3.11 | 1,271,136 (Direct) | View |
| 2020-02-21 Tax Withholding | 2020-02-24 4:30 pm | N/A N/A | RESEARCH FRONTIERS INC | REFR | VAN VOORHEES SETH CFO & VP-Business Development | 22,158 | $1.06 | 1,271,136 (Direct) | View |
| 2020-02-21 Tax Withholding | 2020-02-24 4:30 pm | N/A N/A | RESEARCH FRONTIERS INC | REFR | VAN VOORHEES SETH CFO & VP-Business Development | 13,717 | $1.83 | 1,271,136 (Direct) | View |
| 2020-02-21 Exercise | 2020-02-24 4:30 pm | 2016-12-31 2026-12-30 | RESEARCH FRONTIERS INC | REFR | VAN VOORHEES SETH CFO & VP-Business Development | 155,091 | $0 | 1,271,136 (Direct) | View |
| 2020-02-21 Tax Withholding | 2020-02-24 4:30 pm | N/A N/A | RESEARCH FRONTIERS INC | REFR | VAN VOORHEES SETH CFO & VP-Business Development | 45,272 | $1 | 1,271,136 (Direct) | View |
| 2020-02-21 Tax Withholding | 2020-02-24 4:30 pm | N/A N/A | RESEARCH FRONTIERS INC | REFR | VAN VOORHEES SETH CFO & VP-Business Development | 5,746 | $2.89 | 1,271,136 (Direct) | View |
| 2019-12-31 Option Award | 2020-01-02 4:00 pm | 2019-12-31 2029-12-30 | RESEARCH FRONTIERS INC | REFR | VAN VOORHEES SETH CFO & VP-Business Development | 20,000 | $0 | 305,191 (Direct) | View |